To the central content area

Listed Companies

:::Listed Companies > Listed Companies Info. > Emerging Stock Board Companies > Listed Company Profile

ESM Companies

For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
Basic information
Chairman President Spokesperson Telephone Address ESM Registration Date
Chiu Jen-yi Chen Han-min Chiang Ming-tsan (02)2627-0835 6F.-3, No.21, Ln.583, Ruiguang Rd.,Neihu Dist., Taipei 11492, Taiwan 2018/08/08
Key businesses
Biotechnology and Medical Care Energenesis Biomedical employs unique ENERGI medicine development platform, activating AMP activated protein kinase (AMPK) and thereby enhancing cellular energy, for the cure of diseases.Energenesis Biomedical Co., Ltd. aspires to become a new star in Taiwan's biomedicine industry.
Market info
Latest trading info Historic trading info
Financial data
Cash flows statement Item
Amount(NTD, in thousands)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
balance sheet
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
profit and loss
Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 Investors may find more detailed information on the company by visiting the Market Observation Post System.。
 The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.